Swanson C, Potter D, Kongable G, Cook C. Update on inpatient glycemic control in hospitals in the United States. Endocr Pract. 2011;17(6):853–61.
Article
PubMed
Google Scholar
Wexler DJ, Meigs JB, Cagliero E, Nathan DM, Grant RW. Prevalence of hyper- and hypoglycemia among inpatients with diabetes. A national survey of 44 US hospitals. Diabetes Care. 2007;30(2):367–9.
Article
PubMed
Google Scholar
Farrokhi F, Klindukhova O, Chandra P, Peng L, Smiley D, Newton C, et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. J Diabetes Sci Technol. 2012;6(5):1022–9.
Article
PubMed
PubMed Central
Google Scholar
Elliott MB, Schafers SJ, McGill JB, Tobin GS. Prediction and prevention of treatment-related inpatient hypoglycemia. J Diabetes Sci Technol. 2012;6(2):302–9.
Article
PubMed
PubMed Central
Google Scholar
Cobaugh DJ, Maynard G, Cooper L, Kienle PC, Vigersky R, Childers D, et al. Enhancing insulin-use safety in hospitals: practical recommendations from an ASHP Foundation expert consensus panel. Am J Health Syst Pharm. 2013;70(16):1404–13.
Article
PubMed
Google Scholar
Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med. 2011;124(11):1028–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Curkendall S, Natoli J, Alexander C, Nathanson B, Haidar T, Dubois R. Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr Pract. 2009;15(4):302–12.
Article
PubMed
Google Scholar
Tsujimoto T, Sugiyama T, Shapiro MF, Noda M, Kajio H. Risk of cardiovascular events in patients with diabetes mellitus on β-blockers. Hypertension. 2017;70(1):103–10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hirsch IB, Boyle PJ, Craft S, Cryer PE. Higher glycemic thresholds for symptoms during β-adrenergic blockade in IDDM. Diabetes. 1991;40(9):1177–86.
Article
CAS
PubMed
Google Scholar
Lager I, Blohme G, Smith U. Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics. Lancet. 1979;1(8114):458–62.
Article
CAS
PubMed
Google Scholar
Kerr D, MacDonald I, Heller S, Tattersall R. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double- blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects. Br J Clin Pharmacol. 1990;29(6):685–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Murad MH, Coto-Yglesias F, Wang AT, Sheidaee N, Mullan RJ, Elamin MB, et al. Drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab. 2009;94(3):741–5.
Article
CAS
PubMed
Google Scholar
Ramanathan R, Cryer PE. Adrenergic mediation of hypoglycemia-associated autonomic failure. Diabetes. 2011;60(2):602–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Farhat R, Su G, Sejling A-S, Knight N, Fisher SJ, Chan O. Carvedilol prevents counterregulatory failure and impaired hypoglycaemia awareness in non-diabetic recurrently hypoglycaemic rats. Diabetologia. 2019;62(4):676–86.
Article
CAS
PubMed
Google Scholar
Tsujimoto T, Sugiyama T, Noda M, Kajio H. Intensive glycemic therapy in patients with type 2 diabetes on β-blockers. Diabetes Care. 2016;39(10):1818–26.
Article
CAS
PubMed
Google Scholar
Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, et al. Effectiveness of prior use of beta-blockers for preventing adverse influences of severe hypoglycemia in patients with diabetes: an observational study. Medicine. 2015;94(39):e1629.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brutsaert E, Carey M, Zonszein J. The clinical impact of inpatient hypoglycemia. J Diabetes Complicat. 2014;28(4):565–72.
Article
PubMed
Google Scholar
Tsujimoto T, Kajio H, Shapiro MF, Sugiyama T. Risk of all-cause mortality in diabetic patients taking beta-blockers. Mayo Clin Proc. 2018;93(4):409–18.
Article
CAS
PubMed
Google Scholar
McGill JB, Bakris GL, Fonseca V, Raskin P, Messerli FH, Phillips RA, et al. Beta-blocker use and diabetes symptom score: results from the GEMINI study. Diabetes Obes Metab. 2007;9(3):408–17.
Article
CAS
PubMed
Google Scholar
American Diabetes A. 15. Diabetes care in the hospital: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S173–81.
Article
Google Scholar
American Diabetes A. 14. Management of diabetes in pregnancy: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S165–72.
Article
Google Scholar
Lleva RR, Thomas P, Bozzo JE, Hendrickson KC, Inzucchi SE. Using the glucometrics website to benchmark ICU glucose control before and after the NICE-SUGAR study. J Diabetes Sci Technol. 2014;8(5):918–22.
Article
PubMed
PubMed Central
Google Scholar
Maynard G, Schnipper JL, Messler J, Ramos P, Kulasa K, Nolan A, et al. Design and implementation of a web-based reporting and benchmarking center for inpatient glucometrics. J Diabetes Sci Technol. 2014;8(4):630–40.
Article
PubMed
PubMed Central
Google Scholar
Umpierrez G, Korytkowski M. Diabetic emergencies—ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222–32.
Article
CAS
PubMed
Google Scholar
Pathak RD, Schroeder EB, Seaquist ER, Zeng C, Lafata JE, Thomas A, et al. Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. integrated health care delivery systems: 2005–2011. Diabetes Care. 2016;39(3):363–70.
Article
CAS
PubMed
Google Scholar
Mathioudakis NN, Everett E, Routh S, Pronovost PJ, Yeh HC, Golden SH, et al. Development and validation of a prediction model for insulin-associated hypoglycemia in non-critically ill hospitalized adults. BMJ Open Diabetes Res Care. 2018;6(1):e000499.
Article
PubMed
PubMed Central
Google Scholar
Cardona S, Gomez PC, Vellanki P, Anzola I, Ramos C, Urrutia MA, et al. Clinical characteristics and outcomes of symptomatic and asymptomatic hypoglycemia in hospitalized patients with diabetes. BMJ Open Diabetes Res Care. 2018;6(1):e000607.
Article
PubMed
PubMed Central
Google Scholar
Zullo AR, Hersey M, Lee Y, Sharmin S, Bosco E, Daiello LA, et al. Outcomes of “diabetes-friendly” vs “diabetes-unfriendly” beta-blockers in older nursing home residents with diabetes after acute myocardial infarction. Diabetes Obes Metab. 2018;20(12):2724–32.
Article
CAS
PubMed
Google Scholar
Thamer M, Ray NF, Taylor T. Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas. Clin Ther. 1999;21(8):1387–400.
Article
CAS
PubMed
Google Scholar
Shorr RI, Ray WA, Daugherty JR, Griffin MR. Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. JAMA. 1997;278(1):40–3.
Article
CAS
PubMed
Google Scholar
Group UKHS. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007;50(6):1140–7.
Article
CAS
Google Scholar
Giugliano D, Maiorino MI, Bellastella G, Chiodini P, Ceriello A, Esposito K. Efficacy of insulin analogs in achieving the hemoglobin A1c target of < 7% in type 2 diabetes: meta-analysis of randomized controlled trials. Diabetes Care. 2011;34(2):510–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Paelestik KB, Jespersen NR, Jensen RV, Johnsen J, Botker HE, Kristiansen SB. Effects of hypoglycemia on myocardial susceptibility to ischemia-reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes. Cardiovasc Diabetol. 2017;16(1):148.
Article
PubMed
PubMed Central
CAS
Google Scholar
Segel SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes. 2002;51(3):724–33.
Article
CAS
PubMed
Google Scholar
Mann SJ. Redefining beta-blocker use in hypertension: selecting the right beta-blocker and the right patient. J Am Soc Hypertens. 2017;11(1):54–65.
Article
CAS
PubMed
Google Scholar
Reveno WS, Rosenbaum H. Propranolol and hypoglycaemia. Lancet. 1968;1(7548):920.
Article
CAS
PubMed
Google Scholar
Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, et al. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors. Diabetes. 1982;31(7):641–7.
Article
CAS
PubMed
Google Scholar
Carey M, Gospin R, Goyal A, Tomuta N, Sandu O, Mbanya A, et al. Opioid receptor activation impairs hypoglycemic counterregulation in humans. Diabetes. 2017;66(11):2764–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hsu CT, Liu IM, Cheng JT. Increase of beta-endorphin biosynthesis in the adrenal gland of streptozotocin-induced diabetic rats. Neurosci Lett. 2002;318(2):57–60.
Article
CAS
PubMed
Google Scholar
Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004;292(18):2227–36.
Article
CAS
PubMed
Google Scholar
Basat O, Ucak S, Seber S, Oztekin E, Altuntas Y. After myocardial infarction carvedilol improves insulin resistance compared to metoprolol. Clin Res Cardiol. 2006;95(2):99–104.
Article
PubMed
Google Scholar
Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334(21):1349–55.
Article
CAS
PubMed
Google Scholar
Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000;283(10):1295–302.
Article
CAS
PubMed
Google Scholar
Everly MJ, Heaton PC, Cluxton RJ Jr. Beta-blocker underuse in secondary prevention of myocardial infarction. Ann Pharmacother. 2004;38(2):286–93.
Article
CAS
PubMed
Google Scholar
Jonas M, Reicher-Reiss H, Boyko V, Shotan A, Mandelzweig L, Goldbourt U, et al. Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group. Am J Cardiol. 1996;77(15):1273–7.
Article
CAS
PubMed
Google Scholar
Zaccardi F, Nystrup Husemoen LL, Thorsted BL, Webb DR, Paul SK, Davies MJ, et al. Selectivity of beta-blockers, cardiovascular and all-cause mortality in people with hypoglycaemia: an observational study. Nutr Metab Cardiovasc Dis. 2019;29(5):481–8.
Article
CAS
PubMed
Google Scholar
Reno CM, Daphna-Iken D, Chen YS, VanderWeele J, Jethi K, Fisher SJ. Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation. Diabetes. 2013;62(10):3570–81.
Article
CAS
PubMed
PubMed Central
Google Scholar